Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| BIOGEN INC. | 108,162 | reported | 24 May 2004 | tx 38+911,303−1,111,995 |
| ILLUMINA, INC. | 8,494 | reported | 31 Dec 2015 | tx 73+207,578−202,884 |
| Dare Bioscience, Inc. | 4,500 | reported | 09 Jul 2025 | tx 32+388,753−366,187 |
| NEUROCRINE BIOSCIENCES INC | 2,567 | reported | 27 May 2026 | tx 50+450,095−254,696 |
| Regulus Therapeutics Inc. | 0 | reported | 25 Jun 2025 | tx 49+2,240,045−302,383 |
| FATE THERAPEUTICS INC | 0 | reported | 05 May 2026 | tx 22+846,752−56,922 |
| Receptos, Inc. | 0 | reported | 27 Aug 2015 | tx 21+2,256,039−15,308,626 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 27 May 2026 | GRANT_AWARD | NEUROCRINE BIOSCIENCES INC | 2,567 | 0.00 USD | deriv |
| 21 May 2026 | EXERCISE | NEUROCRINE BIOSCIENCES INC | 3,318 | 0.00 USD | |
| 21 May 2026 | EXERCISE | NEUROCRINE BIOSCIENCES INC | 3,318 | 0.00 USD | deriv |
| 05 May 2026 | EXERCISE | FATE THERAPEUTICS INC | 25,000 | 1.69 USD | |
| 05 May 2026 | EXERCISE | FATE THERAPEUTICS INC | 25,000 | 0.00 USD | deriv |
| 05 Nov 2025 | EXERCISE | NEUROCRINE BIOSCIENCES INC | 18,000 | 47.89 USD | |
| 05 Nov 2025 | SALE | NEUROCRINE BIOSCIENCES INC | 18,000 | 151.82 USD | |
| 05 Nov 2025 | EXERCISE | NEUROCRINE BIOSCIENCES INC | 18,000 | 0.00 USD | deriv |
| 09 Jul 2025 | GRANT_AWARD | Dare Bioscience, Inc. | 4,500 | 0.00 USD | deriv |
| 25 Jun 2025 | TENDER | Regulus Therapeutics Inc. | 44,264 | — | |
| 25 Jun 2025 | OTHER | Regulus Therapeutics Inc. | 57,292 | — | |
| 25 Jun 2025 | OTHER | Regulus Therapeutics Inc. | 2,325 | — | deriv |
| 25 Jun 2025 | OTHER | Regulus Therapeutics Inc. | 4,650 | — | deriv |
| 25 Jun 2025 | OTHER | Regulus Therapeutics Inc. | 4,000 | — | deriv |
| 25 Jun 2025 | OTHER | Regulus Therapeutics Inc. | 9,000 | — | deriv |
| 25 Jun 2025 | OTHER | Regulus Therapeutics Inc. | 30,000 | — | deriv |
| 25 Jun 2025 | OTHER | Regulus Therapeutics Inc. | 15,000 | — | deriv |
| 25 Jun 2025 | OTHER | Regulus Therapeutics Inc. | 30,000 | — | deriv |
| 25 Jun 2025 | OTHER | Regulus Therapeutics Inc. | 60,000 | — | deriv |
| 29 May 2025 | GRANT_AWARD | FATE THERAPEUTICS INC | 55,000 | 0.00 USD | deriv |
| 22 May 2025 | EXERCISE | NEUROCRINE BIOSCIENCES INC | 2,869 | 0.00 USD | |
| 22 May 2025 | EXERCISE | NEUROCRINE BIOSCIENCES INC | 2,869 | 0.00 USD | deriv |
| 21 May 2025 | GRANT_AWARD | NEUROCRINE BIOSCIENCES INC | 3,318 | 0.00 USD | deriv |
| 05 May 2025 | EXERCISE | NEUROCRINE BIOSCIENCES INC | 30,000 | 42.76 USD | |
| 05 May 2025 | SALE | NEUROCRINE BIOSCIENCES INC | 30,000 | 110.20 USD |
3 purchases reported after at least 12 months of silence — most recent on 07 May 2019.